2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Motor Activity
3
Neoplasms
2
Neoplasm Metastasis
2
Breast Neoplasms
2
Stomach Neoplasms
1
Sarcopenia
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lung Neoplasms
1
Infections
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
pembrolizumab
185
Gemcitabine
170
Paclitaxel
152
Carboplatin
137
Bevacizumab
128
Surveys and Questionnaires
118
Cisplatin
115
Docetaxel
114
Blood Specimen Collection
110
Cyclophosphamide
109
Exercise
108
Nivolumab
98
Fluorouracil
90
Capecitabine
86
Dexamethasone
81
Radiotherapy
80
Irinotecan
74
Standard of Care
69
Pemetrexed
68
Oxaliplatin
68
Leucovorin
64
Drug Therapy
64
Cetuximab
60
Erlotinib Hydrochloride
56
Sorafenib
53
atezolizumab
52
Ipilimumab
51
Doxorubicin
50
trametinib
47
Interviews as Topic
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplasms
×
Wearable Electronic Devices
×
Clear all
NCT07030998
2025-11-17
WEARABLES
Murdoch Childrens Research Institute
Recruiting
150 enrolled
NCT03757182
2024-08-27
DigiSTEPS
Cedars-Sinai Medical Center
Active not recruiting
80 enrolled